1. Gilrnan S.C., Lewis A.J. Immunodulatory drugs in the treatment of rheumatoid arthritis. In: Rainsford K.D., ed. Anti-inflammatory and anti-rheumatic drugs, Vol. 3., Anti-rheumatic drugs, experimental agents and clinical aspects of drug use. Boca Raton, FL: CRC Press; 1985:127–154.
2. Keown P.A. Emerging indications for the use of cyclosporin in organ transplantation and autoimmunity. Drugs. 1990;40:315–325.
3. Shand N., Richardson B. Sandimmum® (cyclosporin A): mode of action and clinical results in rheumatoid arthritis. Scand J Rheumatol (Suppl. 76). 1988:265–278.
4. Harding M.W., Handschumacher R.E. Cyclosporin and its receptor, cyclophilin. In: Lewis A., Ackerman N., Otterness I., eds. New perspectives in anti-inflammatory therapies. Advances in inflammation research, Vol. 12. New York: Raven Press; 1988:283–294.
5. Borel J.F. The history of cyclosporin A and its significance. In: White D., ed. Cyclosporin A. Amsterdam: Elsevier; 1982:5–17.